Maharashtra FDA Issues Notices To Bollywood Actors Over Vimal Ads

MEDIA-AND-ENTERTAINMENT
Whalesbook Logo
AuthorAarav Shah|Published at:
Maharashtra FDA Issues Notices To Bollywood Actors Over Vimal Ads

The Maharashtra Food and Drug Administration has issued show-cause notices to Shah Rukh Khan, Ajay Devgn, and Tiger Shroff regarding their Vimal Elaichi advertisements. The regulator alleges these campaigns constitute surrogate advertising for Vimal Pan Masala, a product banned in the state due to tobacco content. This move signals stricter regulatory oversight on celebrity endorsements of potentially restricted products.

The Maharashtra Food and Drug Administration (FDA) has escalated its regulatory oversight by issuing show-cause notices to prominent Bollywood actors Ajay Devgn, Shah Rukh Khan, and Tiger Shroff. The notices, issued this week, stem from the actors' involvement in promotional campaigns for the Vimal Elaichi brand. The regulator has alleged that these advertisements act as surrogate marketing for Vimal Pan Masala, which is currently prohibited in Maharashtra.

Understanding Surrogate Advertising and Legal Risk

The FDA’s action centers on the concept of surrogate advertising, a practice where brands promote restricted or banned products by advertising a substitute item with the same brand name. The Maharashtra state government has maintained a long-standing ban on the manufacture, distribution, and sale of pan masala and gutkha products containing tobacco or nicotine. Under the Food Safety and Standards (FSS) Act, 2006, the regulator argues that the Vimal Elaichi brand is being used to keep the Vimal Pan Masala brand top-of-mind for consumers, circumventing the state's prohibition.

Regulatory officials have cited Section 24 of the FSS Act, which deals with restrictions on advertisements of food products, and Section 53, which outlines penalties for such violations. The potential consequences of this regulatory action are significant. The actors named in the notices could face fines ranging from Rs 10 lakh to Rs 50 lakh if violations are proven. Furthermore, the FDA has the authority to recommend bans on these endorsers, potentially preventing them from participating in future brand campaigns for up to three years.

Impact on Brand Endorsements

This development is part of a broader crackdown by the Maharashtra FDA, led by Commissioner Tukaram Mundhe, against products that violate public health regulations. The state has actively worked to curb the availability of tobacco-laced products, often invoking stringent laws to target both manufacturers and distributors. For the FMCG sector, this case marks a critical point of friction between brand marketing strategies and regulatory compliance.

The actors have been given 15 days to respond to the show-cause notices. They have also been directed to stop participating in the current promotional campaign and to remove related content from digital platforms. For investors and market observers, the key monitorable will be how the brand owner, Vishnu Pouch Packaging Private Limited, and the celebrity endorsers navigate this legal challenge. Any shift in the company’s marketing strategy or regulatory decisions regarding surrogate advertising could influence how other major consumer goods brands approach their advertising campaigns in the future.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.